EnteroMedics (St. Paul, Minnesota), a company that develops devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, said it has completed enrollment and device implantation in its ReCharge pivotal trial for obesity. Read More
